한글목차

세계의 암 치료제 시장 규모는 2023년 1,964억 달러에서 예측 기간 중 12.7%의 CAGR로 추이하며, 2029년에는 4,014억 달러에 달할 것으로 예측됩니다.

표적치료 부문은 2023년 804억 달러에서 14.1%의 CAGR로 추이하며, 2029년에는 1,766억 달러에 달할 것으로 예측됩니다. 면역치료 부문은 2023년 754억 달러에서 12.6%의 CAGR로 추이하며, 2029년에는 1,525억 달러에 달할 것으로 예측됩니다.

세계의 암 치료제 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 법규제 환경, 신규 기술 및 기술개발의 동향, 시장 규모 추이·예측, 각종 구분·지역별 상세 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 개요

• 시장 전망
• 조사 범위
• 시장 개요

제2장 시장 개요

• 개요
• 공급망 분석
• 연구개발
• 제조
• 포장
• 도매·재포장
• 약국
• 소비자에 대한 분배
• 의약품 공급망의 과제 대처
• 비용
• 규칙
• 안전·보안
• Porter's Five Forces 분석

제3장 시장 역학

• 시장 역학
• 시장 성장 촉진요인
• 암 발증률의 증가
• 항암제의 순조로운 승인
• 암치료에서 기술의 진보
• 시장이 해결해야 할 과제
• 독점성의 상실과 일반화
• 종양학 전문가의 부족

제4장 새로운 동향과 파이프라인 분석

• 신규 기술
• 맞춤형 암 백신
• CAR T 세포치료
• 유방암 리스크를 경감하는 태블릿
• 나노입자
• 가압 복강내 에어로졸 화학요법(PIPAC)
• 새로운 개발
• 바이오시밀러의 승인
• 파이프라인 분석
• 임상시험 분석
• 특허 분석

제5장 시장 세분화 분석

• 세분화 내역
• 세계의 암 치료제 시장 : 약제 유형별
• 면역치료
• 표적치료
• 화학요법
• 호르몬 요법
• 세계의 암 치료제 시장 : 암 유형별
• 폐암
• 유방암
• 백혈병
• 악성 흑색종
• 다발성골수종
• 전립선암
• 비호지킨림프종
• 대장암
• 기타 암
• 지역적 내역
• 세계의 암 치료제 시장 : 지역별
• 북미
• 유럽
• 아시아태평양
• 기타

제6장 경쟁 정보

• 개요
• 종양의 블록버스터 의약품 브랜드
• 주요 기업의 시장 점유율

제7장 암 치료제 시장의 지속가능성 : ESG 관점

• 제약업에서 ESG의 역할
• 환경
• 사교
• 거버넌스
• ESG 리스크 평가
• 결론

제8장 부록

• 조사 방법
• 전시
• 두자어
• 기업 개요
• ABBVIE INC.
• AMGEN INC.
• ASTRAZENECA
• BRISTOL-MYERS SQUIBB CO.
• F. HOFFMANN-LA ROCHE LTD.
• JOHNSON & JOHNSON SERVICES INC.
• LILLY
• MERCK & CO. INC.
• NOVARTIS AG
• PFIZER INC.
• SANOFI
• TAKEDA PHARMACEUTICAL CO. LTD.

영문목차

The global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.

The targeted therapy market for oncology pharmaceuticals is estimated to increase from $80.4 billion in 2023 to reach $176.6 billion by 2029, at a CAGR of 14.1% from 2024 through 2029.

The immunotherapy market for oncology pharmaceuticals is estimated to increase from $75.4 billion in 2023 to reach $152.5 billion by 2029, at a CAGR of 12.6% from 2024 through 2029.

Report Scope

This report seeks to deliver an in-depth analysis of the worldwide oncology pharmaceuticals (cancer medications) market. It includes a thorough overview of various types of oncology drugs, such as targeted therapy, immunotherapy, chemotherapy, and hormone therapy, and an examination of current and historical market revenues. The oncology pharmaceuticals market is further categorized by indication, including lung cancer, multiple myeloma, breast cancer, non-Hodgkin's lymphoma, prostate cancer, colorectal cancer, and other types of cancer. Additionally, the report presents the market revenue for each geographic region, including North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

In order to provide an in-depth understanding of the market, this report also includes profiles of market participants, the competitive landscape, key competitors, and respective market share/ranking. This report includes an oncology pharmaceuticals pipeline analysis, patent analysis, and a detailed discussion of key marketed products. This report outlines the driving and restraining factors of the oncology pharmaceuticals market.

By geography, the market in this report is segmented into four regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.

Report Includes

• 70 data tables and 50 additional tables
• Analysis of the global market for oncology pharmaceuticals (cancer drugs)
• Analyses of global market trends, with market revenue data from 2022 to 2023, estimates for 2024, forecast for 2025, and projected CAGRs through 2029
• An assessment of the different oncology pharmaceutical types (targeted therapy, immunotherapy, chemotherapy and hormone therapy) and their current and historical market revenues
• Estimate of the current market size and revenue prospects, along with a market share analysis by drug type, disease indication (application type), and region
• Facts and figures pertaining to the market dynamics, technological advances, regulations, and the macroeconomic factors that influence the industry
• A Porter's Five Forces model, and global supply chain and PESTLE analyses
• An analysis of the key products on the market and promising new pipeline molecules or drugs under development
• A look at the recent patent grants
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies
• Analysis of the industry structure, including companies' market shares, strategic alliances, M&A activity and a venture funding outlook
• Company profiles of major players within the industry, including Bristol-Myers Squibb Co., Merck & Co. Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., and AstraZeneca.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Supply Chain Analysis
• Research and Development
• Manufacturing
• Packaging
• Wholesale Distributors and Repackagers
• Pharmacies
• Dispensed to Consumers
• Addressing Challenges in the Pharmaceutical Supply Chain
• Costs
• Regulations
• Safety and Security
• Porter's Five Forces Analysis in the Oncology Market
• Threat of New Entrants
• Bargaining Power of Suppliers
• Bargaining Power of Buyers
• Threat of Substitute Products or Services
• Industry Rivalry

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Increasing Incidence of Cancer Disease
• Robust Approval of Oncology Drugs
• Technological Advances in Cancer Treatments
• Market Challenges
• Loss of Exclusivity and Genericization
• Lack of Oncology Professionals

Chapter 4 Emerging Trends and Pipeline Analysis

• Emerging Technologies
• Personalized Cancer Vaccines
• CAR T-Cell Therapy
• Tablet to Cut Breast Cancer Risk
• Nanoparticles
• Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)
• New Developments
• Biosimilar Approvals
• Pipeline Analysis
• Clinical Trial Analysis
• Patent Analysis

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Global Oncology Pharmaceuticals Market by Drug Type
• Immunotherapy
• Targeted Therapy
• Chemotherapy
• Hormone Therapy
• Global Oncology Pharmaceuticals Market by Cancer Type
• Lung Cancer
• Breast Cancer
• Leukemia
• Melanoma
• Multiple Myeloma
• Prostate Cancer
• Non-Hodgkin's Lymphoma
• Colorectal Cancer
• Other Cancers
• Geographic Breakdown
• Global Oncology Pharmaceuticals Market by Region
• North America
• Europe
• Asia-Pacific
• Rest of World

Chapter 6 Competitive Intelligence

• Overview
• Blockbuster Oncology Pharmaceutical Brands
• Global Market Shares of Leading Companies

Chapter 7 Sustainability in the Oncology Pharmaceuticals Market: ESG Perspective

• Role of ESG in the Pharma Industry
• Environmental
• Social
• Governance
• ESG Risk Ratings
• Conclusion

Chapter 8 Appendix

• Methodology
• Sources
• Acronyms
• Company Profiles
• ABBVIE INC.
• AMGEN INC.
• ASTRAZENECA
• BRISTOL-MYERS SQUIBB CO.
• F. HOFFMANN-LA ROCHE LTD.
• JOHNSON & JOHNSON SERVICES INC.
• LILLY
• MERCK & CO. INC.
• NOVARTIS AG
• PFIZER INC.
• SANOFI
• TAKEDA PHARMACEUTICAL CO. LTD.